NIVF — NewGenIvf Group Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1981662 ·
Last close
$0.49
Market Cap
$2.93M
52W High
$3.60
52W Low
$0.45
ADV30
508,785
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,424,554 | 524,025 | -4,973,594 | -7,668,922 | 32,722,769 | 758,621 | 6,736,076 |
| Sep 2025 | 1,282,251 | 118,017 | -2,512,491 | 16,823,355 | 35,558,394 | 295,289 | 6,819,059 |
| Dec 2024 | 1,273,612 | 539,135 | -1,089,120 | -108,243 | — | — | — |
| Sep 2024 | 1,472,861 | 648,827 | 216,311 | -19,857 | — | — | — |
Balance + Analyst (yfinance extras)
Retained Earnings
$8,893,414
Inventory
$335,360
Receivables
$1,069,084
ST Investments
—
EBIT TTM
$9,400,046
Pretax Income TTM
$8,488,007
Interest Exp TTM
$912,039
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,726,433
EBITDA
$-10,538,352
Free Cash Flow
$-10,464,332
Enterprise Value
$3,377,127
Total Cash
$958,556
Total Debt
$4,870,307
Shares Out
5,919,948
Trailing EPS
$109.44
Book Value
$331.51
ROE
79.4%
ROA
-36.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,726,433 | -10,726,461 | 9,879,408 | 32,722,769 | 6,736,076 | — | -10,926,056 |
| Dec 2024 | 5,433,375 | -1,160,495 | -524,643 | 3,577,744 | 5,059,501 | — | -8,264,074 |
| Dec 2023 | 5,136,153 | 42,242 | 130,193 | 4,486,996 | 1,241,435 | — | -1,766,135 |
| Dec 2022 | 5,944,190 | 398,705 | 458,667 | 2,904,966 | 2,804,283 | — | 1,710,901 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$28.02
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDIX | Cardiff Lexington Corp | $3.13M | $0.20 | — |
| ATPC | Agape ATP Corp | $2.38M | $2.38 | — |
| XCRT | Xcelerate, Inc. | $4.42M | $0.01 | — |
| BGLC | BioNexus Gene Lab Corp | $4.55M | $1.55 | — |
| LUDG | LUDWIG ENTERPRISES, INC. | $1.67M | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
2026-08-17 12:30 · Yahoo
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
2026-07-30 12:30 · Yahoo
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
2026-07-27 12:30 · Yahoo
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
2026-06-22 12:30 · Yahoo
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
2026-06-18 12:30 · Yahoo
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
2026-06-16 12:30 · Yahoo
NewGen Adds to K25.ai Investment as AI Prediction Market Push Deepens
2026-06-04 17:41 · Yahoo
NIVF Management Continues Aggressive AI Expansion
2026-05-22 09:15 · Yahoo
NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
2026-05-21 12:30 · Yahoo
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
2026-05-04 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.